- Home
- LPCN vs HXHX Comparison
LPCN vs HXHX Comparison
Compare LPCN & HXHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- HXHX
- Stock Information
- Founded
- LPCN 1997
- HXHX 2003
- Country
- LPCN United States
- HXHX China
- Employees
- LPCN N/A
- HXHX N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- HXHX Trucking Freight/Courier Services
- Sector
- LPCN Health Care
- HXHX Industrials
- Exchange
- LPCN Nasdaq
- HXHX Nasdaq
- Market Cap
- LPCN 18.2M
- HXHX 16.8M
- IPO Year
- LPCN N/A
- HXHX 2025
- Fundamental
- Price
- LPCN $2.75
- HXHX $1.03
- Analyst Decision
- LPCN Strong Buy
- HXHX
- Analyst Count
- LPCN 1
- HXHX 0
- Target Price
- LPCN $8.00
- HXHX N/A
- AVG Volume (30 Days)
- LPCN 59.3K
- HXHX 96.6K
- Earning Date
- LPCN 11-07-2025
- HXHX 11-20-2025
- Dividend Yield
- LPCN N/A
- HXHX N/A
- EPS Growth
- LPCN N/A
- HXHX N/A
- EPS
- LPCN N/A
- HXHX 0.26
- Revenue
- LPCN $4,208,119.00
- HXHX $25,571,810.00
- Revenue This Year
- LPCN N/A
- HXHX N/A
- Revenue Next Year
- LPCN N/A
- HXHX N/A
- P/E Ratio
- LPCN N/A
- HXHX $3.89
- Revenue Growth
- LPCN N/A
- HXHX N/A
- 52 Week Low
- LPCN $2.65
- HXHX $0.84
- 52 Week High
- LPCN $6.17
- HXHX $6.29
- Technical
- Relative Strength Index (RSI)
- LPCN 38.39
- HXHX N/A
- Support Level
- LPCN $2.75
- HXHX N/A
- Resistance Level
- LPCN $2.92
- HXHX N/A
- Average True Range (ATR)
- LPCN 0.14
- HXHX 0.00
- MACD
- LPCN -0.04
- HXHX 0.00
- Stochastic Oscillator
- LPCN 6.12
- HXHX 0.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.